DaVita Inc. Files 2024 10-K, Discloses Debt Maturities

Ticker: DVA · Form: 10-K · Filed: 2025-02-13T00:00:00.000Z

Sentiment: neutral

Topics: 10-K, debt, financials

TL;DR

DaVita's 2024 10-K is out. Lots of debt coming due soon, rates vary. Keep an eye on cash flow.

AI Summary

DaVita Inc. filed its 2024 10-K on February 13, 2025, reporting on its fiscal year ending December 31, 2024. The company, a provider of kidney dialysis services, detailed its financial performance and operational status. Key financial figures and debt obligations were disclosed, including various tranches of debt maturing between 2025 and 2027, with interest rates ranging from 1.10% to 4.70%.

Why It Matters

This filing provides investors and analysts with a comprehensive overview of DaVita's financial health and future obligations, crucial for assessing the company's stability and investment potential.

Risk Assessment

Risk Level: medium — The company has significant debt obligations maturing in the near term, which could pose a risk if not managed effectively.

Key Numbers

2024 — Fiscal Year (Reporting period for the 10-K)
20250213 — Filing Date (Date the 10-K was submitted to the SEC)
1.10% — Lowest Debt Interest Rate (Represents the lowest rate on disclosed debt obligations)
4.70% — Highest Debt Interest Rate (Represents the highest rate on disclosed debt obligations)
2025-2027 — Debt Maturity Window (Period during which significant debt obligations are due)

Key Players & Entities

DAVITA INC. (company) — Filer of the 10-K
20241231 (date) — Fiscal year end
20250213 (date) — Filing date
DENVER (location) — Company headquarters city
DE (location) — State of incorporation
1.10% (dollar_amount) — Lowest interest rate on debt
4.70% (dollar_amount) — Highest interest rate on debt
2025 (date) — Earliest debt maturity year
2027 (date) — Latest debt maturity year

FAQ

What was DaVita's total revenue for the fiscal year 2024?

The provided text does not explicitly state the total revenue for fiscal year 2024. It focuses on debt and interest expense details.

What is the total amount of debt maturing between 2025 and 2027?

The filing indicates multiple debt tranches maturing within this period, with amounts like $1,533,635, $1,828,245, $1,000,000, $500,000, $250,000, and $750,000 listed, but a consolidated total is not immediately apparent from this snippet.

What are the specific interest rates for DaVita's debt?

Interest rates mentioned range from 1.10% to 4.70%, with some debt also referencing 'Base + 1.75%'.

When did DaVita Inc. change its name from DaVita Healthcare Partners Inc.?

The name change from DaVita Healthcare Partners Inc. to DaVita Inc. occurred on November 7, 2012.

What is DaVita's Standard Industrial Classification (SIC) code?

DaVita Inc.'s SIC code is 8090, categorized under SERVICES-MISC HEALTH & ALLIED SERVICES, NEC.

From the Filing

0000927066-25-000012.txt : 20250213 0000927066-25-000012.hdr.sgml : 20250213 20250213172547 ACCESSION NUMBER: 0000927066-25-000012 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 140 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250213 DATE AS OF CHANGE: 20250213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 25621766 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 10-K 1 dva-20241231.htm 10-K dva-20241231 false FALSE 2024 FY 0000927066 0.001 5,000 — 0.001 450,000 80,536 88,824 No 10 six months six months no no no 2036-12-31 2029-12-31 2044-12-31 2026-12-31 2025-12-31 21.00 21.00 21.00 3.40 2.60 3.80 1.10 1.10 1.60 0.70 1.20 1.10 0.30 0.20 2.20 0.50 1.10 1.10 0.10 0.80 1.20 1.20 1.20 1.20 0.30 1.90 1.10 4.70 5.60 6.00 18.30 18.70 20.50 http://fasb.org/us-gaap/2024#InterestAndDebtExpense http://fasb.org/us-gaap/2024#IncomeTaxExpenseBenefit Base + 1.75% 1,533,635 1,828,245 1,000,000 3.75 6/30/2024 12/31/2025 500,000 500,000 1,000,000 6/30/2024 12/31/2025 250,000 750,000 1,000,000 6/30/2024 12/31/2025 250,000 750,000 500,000 6/30/2024 12/31/2026 500,000 250,000 4.50 12/31/2024 12/31/2025 250,000 750,000 4.00 12/31/2024 12/31/2026 250,000 500,000 1,750,000 12/31/2025 12/31/2027 750,000 1,000,000 750,000 12/31/2025 12/31/2027 250,000 500,000 http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityCurrent http://fasb.org/us-gaap/2024#OperatingLeaseLiabilityNoncurrent 689,130 692,834 679,815 4.58 4.58 4.51 1 2 3 4 0 50.01 60.00 60.01 70.00 70.01 80.00 100.01 110.00 110.01 120.00 100 no no no no no no no 329,302 2,904 0 0 0 0 0 — — — 0 0 0 iso4217:USD xbrli:shares iso4217:USD xbrli:shares dva:clinic dva:state dva:patient dva:country xbrli:pure dva:entity dva:Segments dva:Clinic 0000927066 2024-01-01 2024-12-31 0000927066 2024-06-30 0000927066 2025-01-31 0000927066 2023-01-01 2023-12-31 0000927066 2022-01-01 2022-12-31 0000927066 2024-12-31 0000927066 2023-12-31 0000927066 2022-12-31 0000927066 2021-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2021-12-31 0000927066 us-gaap:CommonStockMember 2021-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000927066 us-gaap:RetainedEarningsMember 2021-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2021-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000927066 us-gaap:ParentMember 2021-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2021-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2022-01-01 2022-12-31 0000927066 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000927066 us-gaap:ParentMember 2022-01-01 2022-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000927066 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000927066 us-gaap:TreasuryStockCommonMember 20